Abstract
Laryngeal squamous cell carcinoma (LSCC) is associated with 20-50% recurrence rate after definitive chemoradiation. The primary purpose of this study is to explore transcriptomic changes that occur in primary and recurrent laryngeal tumors in order to determine new genetic targets underpinning the development and recurrence of LSCC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
